Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Integrated Chromosome 19 Transcriptomic and Proteomic Datasets Derived from Six Glioma-Derived Cancer Stem Cell Lines

Författare

  • Cheryl Lichti
  • Huiling Liu
  • A.S. Shavkunov
  • Elisabet Mostovenko
  • E.P. Sulman
  • R. Ezhilarasan
  • Q Wang
  • Roger Kroes
  • J.C. Moskal
  • David Fenyö
  • B.A. Oksuz
  • Charles A. Conrad
  • Fredrick F. Lang
  • Frode S. Berven
  • Ákos Végvári
  • Melinda Rezeli
  • György Marko-Varga
  • Sofia Hober
  • Carol L. Nilsson

Summary, in English

One subproject within the global Chromosome 19 Consortium is to define chromosome 19 gene and protein expression in glioma-derived cancer stem cells (GSCs). Chromosome 19 is notoriously linked to glioma by 1p/19q codeletions, and clinical tests are established to detect that specific aberration. GSCs are tumor-initiating cells and are hypothesized to provide a repository of cells in tumors that can self-replicate and be refractory to radiation and chemotherapeutic agents developed for the treatment of tumors. In this pilot study, we performed RNA-Seq, label-free quantitative protein measurements in six GSC lines, and targeted transcriptomic analysis using a chromosome 19-specific microarray in an additional six GSC lines. The data have been deposited to the ProteomeXchange with identifier PXD000563. Here we present insights into differences in GSC gene and protein expression, including the identification of proteins listed as having no or low evidence at the protein level in the Human Protein Atlas, as correlated to chromosome 19 and GSC subtype. Furthermore, the upregulation of proteins downstream of adenovirus-associated viral integration site 1 (AAVS1) in GSC11 in response to oncolytic adenovirus treatment was demonstrated. Taken together, our

results may indicate new roles for chromosome 19, beyond the 1p/19q codeletion, in the future of personalized medicine for glioma patients.

Publiceringsår

2014

Språk

Engelska

Sidor

191-199

Publikation/Tidskrift/Serie

Journal of Proteome Research

Volym

13

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

The American Chemical Society (ACS)

Ämne

  • Medical Engineering

Nyckelord

  • Chromosome-centric Human Proteome Project
  • proteins
  • mRNA
  • RNA-Seq
  • mass spectrometry
  • Bioinformatics
  • glioma
  • glioma stem cells
  • cancer proteomics
  • chromosome 19
  • oncolytic virus
  • neurocan core protein
  • symplekin

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 1535-3893